molecular entity cisplatin [H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H] InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2 CAS:15663-27-1 Peyrone's chloride MolBase:25 Cisplatin Peyrone's salt cis-diamminedichloroplatinum PMID:23554447 Cl2H6N2Pt Patent:DE2318020 300.04452 PMID:18472761 CHEBI:3722 Neoplatin cis-Diamminedichloroplatinum(II) cis-dichlorodiammineplatinum(II) CDDP H6Cl2N2Pt Platinol yes (SP-4-2)-diamminedichloroplatinum PMID:23651576 Cismaplat 298.95560 PMID:12537968 PMID:10883661 PMID:28494534 HMDB:HMDB0014656 PMID:12935404 CHEBI:27899 cis-diammineplatinum(II) dichloride PMID:1855275 Gmelin:2519 chebi_ontology cisplatinum KEGG:C06911 PMID:12831510 A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a cis planar configuration around the central platinum ion. An anticancer drug that interacts with, and forms cross-links between, DNA and proteins, it is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary. Commonly but incorrectly described as an alkylating agent due to its mechanism of action (but it lacks alkyl groups). Reaxys:11324567 PMID:16327988 KEGG:D00275 MetaCyc:CPD0-1392 PMID:23604226 LXZZYRPGZAFOLE-UHFFFAOYSA-L Wikipedia:Cisplatin Patent:DE2329485 Platinex DrugBank:DB00515 [PtCl2(NH3)2] Randa Briplatin cis-diamminedichloridoplatinum(II) Lederplatin cis-platin 0 cisplatino (SP-4-2)-diamminedichloridoplatinum cis-[PtCl2(NH3)2] cisplatine CHEBI:23314 cisplatin cis-DDP Platamine cis-diamminedichloroplatinum(II)